AUS
NZ
UK
CA
USA
IND
Highlights:
- LivaNova’s market capitalization and price-to-earnings ratio reflect its role in the healthcare sector.
- Fluctuations in stock price are observed between the 12-month low and high.
- Key financial ratios, such as quick ratio and debt-to-equity ratio, suggest financial stability.
The healthcare sector plays a significant role in driving advancements in medical technology and patient care. LivaNova, a company specializing in medical devices and pharmaceuticals, is a key entity in this field. Its stock performance and financial metrics offer insight into its position within the industry.
Stock Performance Overview
LivaNova’s (NASDAQ:LIVN) stock has demonstrated notable price variation over the past year, ranging between a low of $43.15 and a high of $64.47. On Wednesday, the stock opened at $47.98, reflecting ongoing market trends. With a market capitalization of $2.61 billion and a price-to-earnings ratio of 114.24, LivaNova’s valuation indicates that the company is considered a significant player within its market segment.
Liquidity and Financial Ratios
LivaNova’s liquidity ratios highlight its ability to meet short-term obligations. The company’s quick ratio stands at 2.87, while the current ratio is 3.37, both suggesting that LivaNova maintains strong liquidity. These metrics indicate the company’s capacity to handle its immediate liabilities with the available assets.
The debt-to-equity ratio of 0.46 indicates that LivaNova employs a conservative approach in managing debt, relying more on equity financing. This ratio provides an understanding of how the company leverages its capital structure to manage financial stability.
Moving Averages and Market Trends
The company’s stock price is currently trading close to its 50-day moving average of $49.65 and its 200-day moving average of $50.19. These moving averages help smooth out fluctuations in daily stock prices, providing a clearer view of the overall trend. The stability in these metrics, combined with favorable liquidity ratios, suggests that LivaNova is positioned to manage market conditions effectively.
LivaNova’s performance is a reflection of its approach to balancing operational efficiency with market realities. The company's market capitalization and financial ratios underscore its solid position in the healthcare sector, where ongoing innovation and regulatory oversight play key roles in shaping industry dynamics
